| |
|
|
| Name: |
Ghost Tree Capital LLC |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10022 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
25 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
APLS |
Apellis Pharmaceuticals Inc |
13 |
New |
$41.11 |
$7,641,000 |
130,000 |
2.46% |
7,641,000 |
130,000 |
0.114 |
N/A |
|
|
BPMC |
Blueprint Medicines Corp |
15 |
New |
$100.57 |
$6,902,000 |
72,761 |
2.22% |
6,902,000 |
72,761 |
0.11 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
20 |
New |
$35.41 |
$5,416,000 |
125,000 |
1.74% |
5,416,000 |
125,000 |
0.176 |
N/A |
|
|
INSM |
Insmed Inc |
25 |
New |
$53.55 |
$4,070,000 |
150,000 |
1.31% |
4,070,000 |
150,000 |
0.099 |
Biotechnology |
|
|
TNYA |
Tenaya Therapeutics, Inc. |
26 |
New |
$0.00 |
$4,053,000 |
775,000 |
1.3% |
4,053,000 |
775,000 |
1.211 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
28 |
New |
$0.60 |
$3,793,000 |
100,000 |
1.22% |
3,793,000 |
100,000 |
0.163 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
30 |
New |
$12.74 |
$3,390,000 |
200,000 |
1.09% |
3,390,000 |
200,000 |
0.862 |
N/A |
|
|
CGON |
CG Oncology, Inc |
31 |
New |
$32.40 |
$3,293,000 |
75,000 |
1.06% |
3,293,000 |
75,000 |
0.114 |
N/A |
|
|
HLXB |
Helix Acquisition Corp. Ii |
33 |
New |
$10.26 |
$3,120,000 |
300,000 |
1% |
3,120,000 |
300,000 |
1.63 |
N/A |
|
|
AQST |
Aquestive Therapeutics, Inc. |
35 |
New |
$3.07 |
$2,995,000 |
702,941 |
0.96% |
2,995,000 |
702,941 |
2.091 |
N/A |
|
|
GERN |
Geron Corporation |
38 |
New |
$3.32 |
$2,640,000 |
800,000 |
0.85% |
2,640,000 |
800,000 |
0.147 |
Drug Manufacturers - ... |
|
|
ALT |
Altimmune, Inc |
40 |
New |
$6.85 |
$2,545,000 |
250,000 |
0.82% |
2,545,000 |
250,000 |
0.509 |
Diversified Investments |
|
|
RGNX |
Regenxbio Inc. |
41 |
New |
$14.11 |
$2,528,000 |
120,000 |
0.81% |
2,528,000 |
120,000 |
0.273 |
N/A |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
45 |
New |
$0.00 |
$2,264,000 |
200,000 |
0.73% |
2,264,000 |
200,000 |
0.363 |
N/A |
|
|
CRBP |
Corbus Pharmaceuticals Hold... |
46 |
New |
$43.50 |
$2,234,000 |
56,941 |
0.72% |
2,234,000 |
56,941 |
0.045 |
N/A |
|
|
LRMR |
Larimar Therapeutics Inc |
53 |
New |
$1.15 |
$1,598,000 |
210,603 |
0.51% |
1,598,000 |
210,603 |
0.527 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
55 |
New |
$0.00 |
$1,308,000 |
600,000 |
0.42% |
1,308,000 |
600,000 |
0.921 |
N/A |
|
|
ELEV |
Elevation Oncology, Inc. |
56 |
New |
$3.97 |
$1,283,000 |
250,000 |
0.41% |
1,283,000 |
250,000 |
0.589 |
N/A |
|
|
NGNE |
Neurogene |
57 |
New |
$3.68 |
$1,273,000 |
25,000 |
0.41% |
1,273,000 |
25,000 |
0.06 |
N/A |
|
|
SGMT |
Sagimet Biosciences Inc. |
58 |
New |
$5.47 |
$1,220,000 |
225,000 |
0.39% |
1,220,000 |
225,000 |
1.053 |
N/A |
|
|
LIFE |
aTyr Pharma Inc |
59 |
New |
$0.37 |
$1,170,000 |
600,000 |
0.38% |
1,170,000 |
600,000 |
1.025 |
N/A |
|
|
ARWR |
Arrowhead Pharmaceuticals Inc |
61 |
New |
$22.87 |
$1,001,000 |
35,000 |
0.32% |
1,001,000 |
35,000 |
0.034 |
Business Services |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
62 |
New |
$38.14 |
$934,000 |
20,000 |
0.3% |
934,000 |
20,000 |
0.024 |
Restaurants |
|
|
ANTX |
An2 Therapeutics Ord Shs |
64 |
New |
$2.09 |
$713,000 |
219,331 |
0.23% |
713,000 |
219,331 |
0.737 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
65 |
New |
$21.67 |
$688,000 |
25,000 |
0.22% |
688,000 |
25,000 |
0.028 |
N/A |
|
